Furthermore, ALA can reverse ketamine-induced SZ-like symptoms in mice, potentially through its influence on BDNF in the PFC, as well as in a mouse model of depression (Vasconcelos et al., 2015; Aliomrani et al., 2022). The gene discussed is BDNF; the disease is depressive disorder.